Mark Cuban: Hospitals Profit More from Accepting Insurance Patients
Billionaire Mark Cuban argued that hospitals profit more overall from accepting Medicaid and Medicare patients rather than incurring losses. He pointed out that the fixed costs for these patients are already covered, with positive marginal contributions, along with additional income from the 340B program profits, state and federal subsidies, etc.
He emphasized that one should not look at the profitability of a single visit in isolation but should assess the overall financial impact of accepting such patients on hospitals. He believes that the compliance costs, denials, and delays brought by commercial insurance payers are more destructive. Cuban publicly invited corrections to learn from them.
Source: Public Information
ABAB AI Insight
The core of this viewpoint is the "fixed cost allocation" mechanism in the healthcare system. Hospitals, as high fixed cost industries (equipment, personnel, facilities), have sunk costs associated with unused capacity, meaning any paying patient (regardless of rate) can contribute positive marginal revenue, especially when combined with government subsidies like 340B and DSH.
The 340B program essentially redistributes pharmaceutical discounts: hospitals acquire drugs at low prices and profit from selling them through normal channels. This policy design aims to compensate for services to low-income patients but actually amplifies the asymmetry in hospital profits, weakening the simplistic narrative of "profitability by patient type."
The "payment game" of commercial insurers reflects a long-term game between payers and providers. Denials, delays, and the role of PBMs (pharmacy benefit managers) create hidden taxes that erode cash flow more than the low rates of government insurance. This determines that hospitals prefer a "stable low yield" payment system rather than a "high variability high cost" one.
Structurally, this exposes the "mixed payment dilemma" in U.S. healthcare: government programs provide volume and stability, while commercial insurance offers high prices but with high friction. Overall profitability relies on policy subsidies and cost control rather than purely market pricing, which determines the industry's extreme sensitivity to regulatory changes.